Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1982
Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms
R Kuczenski, D S Segal, S B Weinberger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1983
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin
B K Koe, A Weissman, W M Welch, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
May 10, 2000
A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder
S R Pliszka, R G Browne, R L Olvera, et al.
Science (New York, N.Y.)
|
October 28, 1977
beta-Endorphin: endogenous opiate or neuroleptic?
D S Segal, R G Browne, F Bloom, et al.
European Journal of Pharmacology
|
July 7, 1988
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents
N E Rhaleb, S Dion, P D'Orléans-Juste, et al.
Peptides
|
January 1, 1989
Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action
F G Ambrose, B S Barbaz, W L Autry, et al.
Journal of Medicinal Chemistry
|
August 1, 1990
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants
R Sarges, H R Howard, R G Browne, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1982
Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms
R Kuczenski, D S Segal, S B Weinberger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1983
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin
B K Koe, A Weissman, W M Welch, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
May 10, 2000
A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder
S R Pliszka, R G Browne, R L Olvera, et al.
Science (New York, N.Y.)
|
October 28, 1977
beta-Endorphin: endogenous opiate or neuroleptic?
D S Segal, R G Browne, F Bloom, et al.
European Journal of Pharmacology
|
July 7, 1988
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents
N E Rhaleb, S Dion, P D'Orléans-Juste, et al.
Peptides
|
January 1, 1989
Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action
F G Ambrose, B S Barbaz, W L Autry, et al.
Journal of Medicinal Chemistry
|
August 1, 1990
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants
R Sarges, H R Howard, R G Browne, et al.
Page
of 2